F. Escamilla Sevilla

Association of Parkinson’s disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records

Javier Pinel Ríos, Carlos Javier Madrid Navarro, M. J. Pérez Navarro, 2019, BMJ Open.

Management of Parkinson’s disease and other movement disorders in women of childbearing age: Part 2

I. Parees, J. Castrillo, B. Pascual-Sedano, 2021 .

[Unilateral papilledema in pseudotumor cerebri].

F. Escamilla Sevilla, A. Aguilera Pérez, F. J. Rodríguez Hurtado, 2001, Archivos de la Sociedad Espanola de Oftalmologia.

Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

F. Escamilla Sevilla, D. Santos García, Juan Manuel Oropesa-Ruiz, 2022, Brain sciences.

MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

J. Kulisevsky, M. Luquin, P. Martínez-Martín, 2021, Diagnostics.

Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

J. Kulisevsky, M. Luquin, P. Martínez-Martín, 2023, Journal of Parkinson's disease.

Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.

P. Mir, F. Escamilla Sevilla, P. G. Garcia Ruiz, 2023, Neurologia.